In biomarker-positive MCI (due-to-AD) and AD Dementia, beyond well-established metabolic and mitochondrial dysfunction, we observed upregulated neuropeptide signaling, G-protein-coupled receptors activity, and synaptic remodeling, highlighting underrecognized synaptic and signaling alterations. This evidence concerns the gene NPS and dementia.